These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30201787)

  • 21. Therapeutic prostate cancer vaccines: a review of the latest developments.
    Mohebtash M; Madan RA; Gulley JL; Arlen PM
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1296-301. PubMed ID: 19037836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in immunotherapy for kidney cancer.
    Ball MW; Allaf ME; Drake CG
    Discov Med; 2016 Apr; 21(116):305-13. PubMed ID: 27232516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer: Better VISTAs ahead? Potential and pitfalls of immunotherapy.
    Madan RA; Gulley JL
    Nat Rev Urol; 2017 Aug; 14(8):455-456. PubMed ID: 28534538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of immunological therapies for prostate cancer.
    Antonarakis ES; Drake CG
    Curr Opin Urol; 2010 May; 20(3):241-6. PubMed ID: 20179598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.
    Patel A; Fong L
    Oncology (Williston Park); 2018 Mar; 32(3):112-20. PubMed ID: 29548065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Oudard S; Thibault C; Angelergues A; Tartour E; Timsit MO; Mejean A; Michel C; Vano Y
    Bull Cancer; 2016 Nov; 103 Suppl 1():S144-S150. PubMed ID: 28057178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications.
    Singh BH; Gulley JL
    Asian J Androl; 2014; 16(3):364-71. PubMed ID: 24435055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer gene therapy.
    Steiner MS; Gingrich JR; Chauhan RD
    Surg Oncol Clin N Am; 2002 Jul; 11(3):607-20. PubMed ID: 12487058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current immunotherapeutic strategies in prostate cancer.
    Grosso JF; Drake CG
    Surg Oncol Clin N Am; 2007 Oct; 16(4):861-71, x. PubMed ID: 18022549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
    Tanimoto T; Hori A; Kami M
    N Engl J Med; 2010 Nov; 363(20):1966; author reply 1967-8. PubMed ID: 21067392
    [No Abstract]   [Full Text] [Related]  

  • 31. Lung cancer: potential targets for immunotherapy.
    Tartour E; Zitvogel L
    Lancet Respir Med; 2013 Sep; 1(7):551-63. PubMed ID: 24461616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular insights into the development of T cell-based immunotherapy for prostate cancer.
    Dong B; Minze LJ; Xue W; Chen W
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1547-57. PubMed ID: 25259804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What's new in the treatment of advanced prostate cancer?
    Sternberg CN
    Eur J Cancer; 2003 Jan; 39(2):136-46. PubMed ID: 12509944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in active specific immunotherapy of prostate cancer.
    Tjoa BA; Murphy GP
    Semin Surg Oncol; 2000; 18(1):80-7. PubMed ID: 10617899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel approaches in cancer immunotherapy -- a light at the end of the tunnel.
    Joshi M; Pal SK; Drabick JJ
    Discov Med; 2016 Jun; 21(118):479-87. PubMed ID: 27448784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination strategies to enhance antitumor ADCC.
    Kohrt HE; Houot R; Marabelle A; Cho HJ; Osman K; Goldstein M; Levy R; Brody J
    Immunotherapy; 2012 May; 4(5):511-27. PubMed ID: 22642334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
    Nabhan C
    N Engl J Med; 2010 Nov; 363(20):1966-7; author reply 1968. PubMed ID: 21067391
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review.
    Janiczek M; Szylberg Ł; Kasperska A; Kowalewski A; Parol M; Antosik P; Radecka B; Marszałek A
    J Immunol Res; 2017; 2017():4861570. PubMed ID: 29109964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy for prostate cancer - recent progress in clinical trials.
    Kipp RT; McNeel DG
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.